These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 15328673)

  • 1. Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of life.
    Lennox RD; Leahy MJ
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):142-6. PubMed ID: 15328673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal important difference (MID) of the Dermatology Life Quality Index (DLQI): results from patients with chronic idiopathic urticaria.
    Shikiar R; Harding G; Leahy M; Lennox RD
    Health Qual Life Outcomes; 2005 May; 3():36. PubMed ID: 15907211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study.
    Kapp A; Pichler WJ
    Int J Dermatol; 2006 Apr; 45(4):469-74. PubMed ID: 16650180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study.
    Kaplan AP; Spector SL; Meeves S; Liao Y; Varghese ST; Georges G
    Ann Allergy Asthma Immunol; 2005 Jun; 94(6):662-9. PubMed ID: 15984599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticaria.
    Spector SL; Shikiar R; Harding G; Meeves S; Leahy MJ
    Cutis; 2007 Feb; 79(2):157-62. PubMed ID: 17388220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life in adults with chronic idiopathic urticaria receiving desloratadine: a randomized, double-blind, multicentre, placebo-controlled study.
    Grob JJ; Auquier P; Dreyfus I; Ortonne JP
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):87-93. PubMed ID: 18181978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria.
    Thompson AK; Finn AF; Schoenwetter WF
    J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):24-30. PubMed ID: 10863219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment on the reliability and validity of the Dermatology Life Quality Index in Chinese version].
    Wang XL; Zhao TE; Zhang XQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Sep; 25(9):791-3. PubMed ID: 15555362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-sedating antihistamines in the treatment of chronic idiopathic urticaria using patient-reported outcomes.
    Grob JJ; Lachapelle JM
    Curr Med Res Opin; 2008 Aug; 24(8):2423-8. PubMed ID: 18651988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter study of the efficacy and safety of fexofenadine 60 mg. twice daily in 108 Thai patients with chronic idiopathic urticaria.
    Kulthanan K; Gritiyarangsan P; Sitakalin C; Charuwichitratana S; Korkij W; Aunhachoke K; Janjumratsang P; Jiamton S; Kuntiranont M; Krisadapong J; Gherunpong N; Kullavanijaya P
    J Med Assoc Thai; 2001 Feb; 84(2):153-9. PubMed ID: 11336071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria.
    Nelson HS; Reynolds R; Mason J
    Ann Allergy Asthma Immunol; 2000 May; 84(5):517-22. PubMed ID: 10831005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The levels of depression, anxiety and quality of life in patients with chronic idiopathic urticaria.
    Engin B; Uguz F; Yilmaz E; Ozdemir M; Mevlitoglu I
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):36-40. PubMed ID: 18181971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Life quality of Chinese patients with chronic urticaria as assessed by the dermatology life quality index.
    Liu JB; Yao MZ; Si AL; Xiong LK; Zhou H
    J Eur Acad Dermatol Venereol; 2012 Oct; 26(10):1252-7. PubMed ID: 21958389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptation and validation of the Urticaria Patient Daily Diary for adolescents.
    Mathias SD; Tschosik EA; Zazzali JL
    Allergy Asthma Proc; 2012; 33(2):186-90. PubMed ID: 22525396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings.
    Młynek A; Magerl M; Hanna M; Lhachimi S; Baiardini I; Canonica GW; Brzoza Z; Kasperska-Zajac A; Rogala B; Zalewska-Janowska A; Zuberbier T; Maurer M
    Allergy; 2009 Jun; 64(6):927-36. PubMed ID: 19453340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life.
    Grob JJ; Auquier P; Dreyfus I; Ortonne JP
    Allergy; 2009 Apr; 64(4):605-12. PubMed ID: 19133920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results.
    Basra MK; Fenech R; Gatt RM; Salek MS; Finlay AY
    Br J Dermatol; 2008 Nov; 159(5):997-1035. PubMed ID: 18795920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the Dermatology Life Quality Index (DLQI) in a midwestern US urban clinic.
    Hahn HB; Melfi CA; Chuang TY; Lewis CW; Gonin R; Hanna MP; Farmer ER
    J Am Acad Dermatol; 2001 Jul; 45(1):44-8. PubMed ID: 11423833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
    Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
    Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study.
    Dubertret L; Murrieta Aguttes M; Tonet J
    J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):16-24. PubMed ID: 10188144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.